The University of Portsmouth is joining forces with brain tumour charity, Brainstrust and other partners to create a centre of excellence for brain tumour research on the South Coast.
Brain tumours are the most lethal and devastating tumours. They are the most common cause of death in children after accidents and the most common form of cancer in people under 40.
The new centre will focus entirely on dedicated laboratory-based brain tumour research in both adults and children.
Professor of Cellular & Molecular Neuro-oncology, Geoff Pilkington, who is leading the research team at Portsmouth, is chairing an open day at the University today to showcase the current facilities and to introduce major collaborators to the University.
Attendees include cricketer Alan Igglesden, the former Kent and England fast bowler, who was first diagnosed with a brain tumour several years ago. He is currently receiving treatment by Professor Pilkington and has long been a supporter of his work.
He and other brain tumour patients will hear about the current neuro-oncology research projects at Portsmouth and about the latest research in the field such as the development of new drug delivery systems to the brain.
Representatives from neurosurgical centres and charities which are currently funding research at the University will also attend, including leading brain tumour charities such as Ali’s Dream, Brain Tumour UK, and Charlie’s Challenge. Other attendees include senior clinical neuro-science staff from Southampton General Hospital and trustees, patrons and key supporters of Brainstrust.
Professor Pilkington said: “The aim of the collaboration between Brainstrust and Portsmouth University is to fund new specialist staff in neuro-oncology to further our research and to raise funds to buy equipment and provide essential running costs.”
Dr Helen Bulbeck is director and co-founder of Brainstrust, the Meg Jones tumour charity. She said: “Brain cancer research attracts relatively very little funding compared to other cancers, such as breast, bowel, lung and prostate. This is why raising awareness through this open day is so important.”
It is anticipated that several clinical leading neuro-oncology centres will provide vital tissues and clinical experience while the University will provide medical research programmes, training courses and a state of the art laboratory.
Those already on-board include Hurstwood Park Neurological Centre, Hayward's Heath, Maidstone NHS Hospitals, King's College Hospital, London & Charing Cross Hospital and the Institute of Neurology in London.
Professor Pilkington said that the centre would encourage institutions to collaborate in order for patients to benefit from a research informed environment.
Lisa Egan | alfa
The Maturation Pattern of the Hippocampus Drives Human Memory Deve
23.07.2018 | Max-Planck-Institut für Bildungsforschung
Cebit 2018: Saarbrücken Start-up combines Tinkering and Programming for Elementary School Kids
05.06.2018 | Universität des Saarlandes
New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference
Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...
Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...
Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.
When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...
Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.
Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....
Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.
Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...
17.08.2018 | Event News
08.08.2018 | Event News
27.07.2018 | Event News
17.08.2018 | Physics and Astronomy
17.08.2018 | Information Technology
17.08.2018 | Life Sciences